专利检索 ap:("Galit Rotman" OR "Merav Beiman" OR "Michal Ayalon-Soffer" OR "Zurit Levine" OR "Chen Hermesh" OR "Anat Oren" OR "Zohar Tiran") AND inv:"Zohar Tiran" 第 1 页

1.

发明授权
Hepatocyte growth factor receptor splice variants and methods of using same 失效
标题翻译：肝细胞生长因子受体剪接变体及其使用方法

公开(公告)号：US07758862B2

公开(公告)日：2010-07-20

申请号：US12088210

申请日：2006-10-03

申请人： Galit Rotman , Merav Beiman , Michal Ayalon-Soffer , Zurit Levine , Chen Hermesh , Anat Oren , Zohar Tiran

发明人： Galit Rotman , Merav Beiman , Michal Ayalon-Soffer , Zurit Levine , Chen Hermesh , Anat Oren , Zohar Tiran

IPC分类号： A61K39/00 , A61K38/00 , C12P71/08 , C07K14/00 , C08H1/00

CPC分类号： C07K14/71 , A61K38/00 , C07K2319/20 , C07K2319/30

摘要： Novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor and polynucleotides encoding same are provided. Methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention, are also provided.

摘要翻译： 提供了作为c-Met的剪接变体，肝细胞生长因子的受体和编码其的多核苷酸的新型多肽。还提供了可用于使用本发明的多肽和多核苷酸治疗各种疾病如癌症，免疫相关，血液相关和皮肤相关疾病的方法和药物组合物。

2.

发明授权
Hepatocyte growth factor receptor splice variants and methods of using same 有权

公开(公告)号：US07678769B2

公开(公告)日：2010-03-16

申请号：US11781905

申请日：2007-07-23

申请人： Galit Rotman , Merav Beiman , Michal Ayalon-Soffer , Zurit Levine , Chen Hermesh , Anat Oren , Zohar Tiran , Dvir Dahary , Liat Mintz , Hanqing Xie

发明人： Galit Rotman , Merav Beiman , Michal Ayalon-Soffer , Zurit Levine , Chen Hermesh , Anat Oren , Zohar Tiran , Dvir Dahary , Liat Mintz , Hanqing Xie

IPC分类号： A61K38/00 , C07K14/00

CPC分类号： C07K14/71 , A61K38/00

摘要： Novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor and polynucleotides encoding same are provided. Methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention, are also provided.

3.

发明申请
HEPATOCYTE GROWTH FACTOR RECEPTOR SPLICE VARIANTS AND METHODS OF USING SAME 审中-公开
标题翻译：肝细胞生长因子受体拮抗剂变异体及其使用方法

公开(公告)号：US20100183573A1

公开(公告)日：2010-07-22

申请号：US12709269

申请日：2010-02-19

申请人： Galit Rotman , Merav Beiman , Michal Ayalon-Soffer , Zurit Levine , Chen Hermesh , Anat Oren , Zohar Tiran , Dvir Dahary , Liat Mintz , Hanqing Xie

发明人： Galit Rotman , Merav Beiman , Michal Ayalon-Soffer , Zurit Levine , Chen Hermesh , Anat Oren , Zohar Tiran , Dvir Dahary , Liat Mintz , Hanqing Xie

IPC分类号： A61K38/16 , C07K14/00 , C07H21/04 , C12N15/63 , C12N1/21 , A61K31/7088 , A61K35/74 , A61K35/66 , C12N1/19 , C12N5/10 , A61K35/64 , A61K35/12 , A61P35/02 , A61P9/10 , A61P37/00

CPC分类号： C07K14/71 , A61K38/00 , C07K16/248 , C07K2317/34 , C07K2317/55 , C07K2317/73

摘要： Novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor and polynucleotides encoding same are provided. Methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention, are also provided.

摘要翻译： 提供了作为c-Met的剪接变体，肝细胞生长因子的受体和编码其的多核苷酸的新型多肽。还提供了可用于使用本发明的多肽和多核苷酸治疗各种疾病如癌症，免疫相关，血液相关和皮肤相关疾病的方法和药物组合物。

4.

发明申请
HEPATOCYTE GROWTH FACTOR RECEPTOR SPLICE VARIANTS AND METHODS OF USING SAME 失效
标题翻译：肝细胞生长因子受体拮抗剂变异体及其使用方法

公开(公告)号：US20090036374A1

公开(公告)日：2009-02-05

申请号：US12088210

申请日：2006-10-03

申请人： Galit Rotman , Merav Beiman , Michal Ayalon-Soffer , Zurit Levine , Chen Hermesh , Anat Oren , Zohar Tiran

发明人： Galit Rotman , Merav Beiman , Michal Ayalon-Soffer , Zurit Levine , Chen Hermesh , Anat Oren , Zohar Tiran

IPC分类号： C07K14/435 , C12N15/62 , C12N15/85 , C12N5/10 , A61K38/17 , A61K31/7088 , A61P35/00 , A61P29/00 , A61P37/00

CPC分类号： C07K14/71 , A61K38/00 , C07K2319/20 , C07K2319/30

摘要： Novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor and polynucleotides encoding same are provided. Methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention, are also provided.

摘要翻译： 提供了作为c-Met的剪接变体，肝细胞生长因子的受体和编码其的多核苷酸的新型多肽。还提供了可用于使用本发明的多肽和多核苷酸治疗各种疾病如癌症，免疫相关，血液相关和皮肤相关疾病的方法和药物组合物。

5.

发明申请
HEPATOCYTE GROWTH FACTOR RECEPTOR SPLICE VARIANTS AND METHODS OF USING SAME 有权
标题翻译：肝细胞生长因子受体拮抗剂变异体及其使用方法

公开(公告)号：US20080159992A1

公开(公告)日：2008-07-03

申请号：US11781905

申请日：2007-07-23

申请人： Galit Rotman , Merav Beiman , Michal Ayalon-Soffer , Zurit Levine , Chen Hermesh , Anat Oren , Zohar Tiran , Dvir Dahary , Liat Mintz , Hanqing Xie

发明人： Galit Rotman , Merav Beiman , Michal Ayalon-Soffer , Zurit Levine , Chen Hermesh , Anat Oren , Zohar Tiran , Dvir Dahary , Liat Mintz , Hanqing Xie

IPC分类号： A01N63/00 , C07K16/00 , C07H21/04 , C12N15/00 , C12N5/00 , A61K38/00 , A61K31/70

CPC分类号： C07K14/71 , A61K38/00

摘要： Novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor and polynucleotides encoding same are provided. Methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention, are also provided.

摘要翻译： 提供了作为c-Met的剪接变体，肝细胞生长因子的受体和编码其的多核苷酸的新型多肽。还提供了可用于使用本发明的多肽和多核苷酸治疗各种疾病如癌症，免疫相关，血液相关和皮肤相关疾病的方法和药物组合物。

6.

发明授权
Clusterin derived peptide 失效
标题翻译： Clusterin衍生肽

公开(公告)号：US08575107B2

公开(公告)日：2013-11-05

申请号：US12863864

申请日：2009-01-22

申请人： Yossef Kliger , Ofer Levy , Itamar Borukhov , Assaf Wool , Ehud Schreiber , Anat Amir , Zurit Levine , Zohar Tiran , Anat Oren , Amir Toporik

发明人： Yossef Kliger , Ofer Levy , Itamar Borukhov , Assaf Wool , Ehud Schreiber , Anat Amir , Zurit Levine , Zohar Tiran , Anat Oren , Amir Toporik

IPC分类号： C07K9/00 , A61K38/00

CPC分类号： C07K14/775 , A61K38/00

摘要： Clusterin-derived peptides or homologues or derivatives thereof, pharmaceutical compositions including the same, methods of manufacturing the peptides, homologues, derivatives thereof and compositions including the same, and methods of treating conditions including administering the peptides, homologues, derivatives thereof and compositions including the same, are provided. Also provided are nucleotide sequences encoding the peptides, homologues, derivatives thereof and compositions including the same, antibodies directed to epitopes thereof and fusion proteins including the same.

摘要翻译： 来自Clusterin的肽或其同系物或衍生物，包含其的药物组合物，制备肽的方法，同系物，其衍生物和包含其的组合物，以及治疗包括给予所述肽，同系物，衍生物和包括相同，被提供。还提供了编码肽，同系物，其衍生物和包含其的组合物的核苷酸序列，涉及其表位的抗体和包括其的融合蛋白。

7.

发明申请
NOVEL CLUSTERIN DERIVED PEPTIDE 失效
标题翻译：新型聚集蛋白衍生肽

公开(公告)号：US20100322938A1

公开(公告)日：2010-12-23

申请号：US12863864

申请日：2009-01-22

申请人： Yossef Kliger , Ofer Levy , Itamar Borukhov , Assaf Wool , Ehud Schreiber , Anat Amir , Zurit Levine , Zohar Tiran , Anat Oren , Amir Toporik

发明人： Yossef Kliger , Ofer Levy , Itamar Borukhov , Assaf Wool , Ehud Schreiber , Anat Amir , Zurit Levine , Zohar Tiran , Anat Oren , Amir Toporik

IPC分类号： A61K39/395 , C07K14/00 , C07K16/00 , C07H21/04 , A61P25/28

CPC分类号： C07K14/775 , A61K38/00

摘要： Clusterin-derived peptides or homologues or derivatives thereof, pharmaceutical compositions including the same, methods of manufacturing the peptides, homologues, derivatives thereof and compositions including the same, and methods of treating conditions including administering the peptides, homologues, derivatives thereof and compositions including the same, are provided. Also provided are nucleotide sequences encoding the peptides, homologues, derivatives thereof and compositions including the same, antibodies directed to epitopes thereof and fusion proteins including the same

摘要翻译： 来自Clusterin的肽或其同系物或衍生物，包含其的药物组合物，制备肽的方法，同系物，其衍生物和包含其的组合物，以及治疗包括给予所述肽，同系物，衍生物和包括相同，被提供。还提供了编码肽，同系物，其衍生物和包含其的组合物的核苷酸序列，针对其表位的抗体和包含其的融合蛋白

8.

发明申请
ANGIOPOIETIN DERIVED PEPTIDES 有权
标题翻译：神经肽衍生肽

公开(公告)号：US20110206760A1

公开(公告)日：2011-08-25

申请号：US13054914

申请日：2009-07-20

申请人： Yossef Kliger , Itamar Borukhov , Ofer Levy , Zohar Tiran , Assaf Wool , Ehud Schreiber , Anat Amir , Zurit Levine , Amir Toporik

发明人： Yossef Kliger , Itamar Borukhov , Ofer Levy , Zohar Tiran , Assaf Wool , Ehud Schreiber , Anat Amir , Zurit Levine , Amir Toporik

IPC分类号： A61K38/16 , C07K14/00 , C07K7/06 , C07K7/08 , C07K16/46 , A61K38/08 , A61K38/10 , A61K9/127 , A61P27/02 , A61P35/00 , A61P29/00 , A61P37/00 , A61P9/00 , A61K39/395 , A61K38/27 , A61K38/20 , A61K38/21 , A61K33/24 , A61P35/02 , A61P37/06 , A61P37/08 , A61P11/06 , A61P7/06 , B82Y5/00

CPC分类号： C07K14/515 , A61K38/14 , A61K38/1891 , A61K45/06 , C07K9/00 , C07K9/001

摘要： Provided are angiopoietin-derived peptides or homologs or derivatives thereof, pharmaceutical composition including them, a use thereof for therapy and for the manufacture of a medicament, a method of treating a wide range of conditions, disorders and diseases therewith, nucleotide sequences encoding them, antibodies directed to epitopes thereof and fusion proteins including them.

摘要翻译： 提供来自血管生成素的肽或其同系物或衍生物，包含它们的药物组合物，其用于治疗和制备药物的用途，治疗各种病症，疾病和疾病的方法，编码它们的核苷酸序列，针对其表位的抗体和包括它们的融合蛋白。

9.

发明授权
Angiopoietin derived peptides 有权
标题翻译：促血管生成素衍生肽

公开(公告)号：US08529943B2

公开(公告)日：2013-09-10

申请号：US13054914

申请日：2009-07-20

申请人： Yossef Kliger , Itamar Borukhov , Ofer Levy , Zohar Tiran , Assaf Wool , Ehud Schreiber , Anat Amir , Zurit Levine , Amir Toporik

发明人： Yossef Kliger , Itamar Borukhov , Ofer Levy , Zohar Tiran , Assaf Wool , Ehud Schreiber , Anat Amir , Zurit Levine , Amir Toporik

IPC分类号： C07K14/515 , C07K14/00 , C07K7/06 , C07K7/08 , C07K16/46 , A61K38/16 , A61K38/08 , A61K38/10

CPC分类号： C07K14/515 , A61K38/14 , A61K38/1891 , A61K45/06 , C07K9/00 , C07K9/001

摘要： Provided are angiopoietin-derived peptides or homologs or derivatives thereof, pharmaceutical composition including them, a use thereof for therapy and for the manufacture of a medicament, a method of treating a wide range of conditions, disorders and diseases therewith, nucleotide sequences encoding them, antibodies directed to epitopes thereof and fusion proteins including them.

摘要翻译： 提供来自血管生成素的肽或其同系物或衍生物，包含它们的药物组合物，其用于治疗和制备药物的用途，治疗各种病症，疾病和疾病的方法，编码它们的核苷酸序列，针对其表位的抗体和包括它们的融合蛋白。